• OPEN AN ACCOUNT
Indian Indices
Nifty
24,273.80 -140.60
(-0.58%)
Sensex
79,445.63 -889.18
( -1.11%)
Bank Nifty
54,365.65 -245.25
( -0.45%)
Nifty IT
36,002.45 82.15
( 0.23%)
Global Indices
Nasdaq
41,380.81 245.84
(0.60%)
Dow Jones
5,684.33 32.05
(0.57%)
Hang Seng
36,949.24 169.58
(0.46%)
Nikkei 225
8,531.61 -27.72
(-0.32%)
Forex
USD-INR
84.70 0.29
(0.35%)
EUR-INR
96.08 0.41
(0.42%)
GBP-INR
112.96 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Indian Metals & Ferro Alloys Ltd
Industry :  Mining / Minerals / Metals
BSE Code
ISIN Demat
Book Value()
533047
INE919H01018
428.0237923
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IMFA
7.49
3140.4
EPS(TTM)
Face Value()
Div & Yield %
77.66
10
1.29
 

hindustan unilever ltd
Prism Medico & Pharmacy Ltd - Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Feb 14,2025
Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the board of directors at their meeting held today i.e. 14th February 2025 which commenced at 01:30 P.M. and concluded at 05:00 P.M. have inter-alia approved the following: The board considered and approved the Unaudited Standalone financial results of the company for the quarter ended 31st December 2024 along with the Limited Review Report duly signed by the auditors of the company.